More Blood Pressure Drugs Recalled
Some lots of losartan contaminated with the cancer-causing chemical N-methylnitrosobutyric acid
FDA
2011 FDA Safety Message Tied to Drop in Transvaginal Mesh Use
Proportion of apical procedures using transvaginal mesh decreased in year after safety communication
FDA: Entacapone Not Associated With Increased Prostate Cancer Risk
The FDA has concluded that the use of entacapone to treat Parkinson disease (PD) does not increase the risk of developing prostate cancer.
FDA Pulls Surgical Mesh for Pelvic Organ Prolapse From the Market
The agency alleges manufacturers failed to provide evidence of the long-term safety of surgical mesh for transvaginal repair of anterior compartment prolapse.
FDA Investigating Paclitaxel Balloons and Stents
Investigation triggered by meta-analysis showing possible increased mortality in PAD patients at 2 years
FDA Down to 5 Weeks of Funding to Review New Drug Applications
Agency cannot accept new fees or applications until the shutdown is over
FDA: Fluoroquinolones Tied to Heart Vessel Ruptures, Tears
Patients at risk include those with hypertension or certain genetic disorders and the elderly
Xyosted Now Available for Treatment of Testosterone Deficiency
Prior to starting Xyosted, the patient’s baseline cardiovascular risk should be considered and blood pressure should be adequately controlled.
FDA to Update Medical Device Approvals Process
Revised process will ensure new medical devices meet safety and effectiveness standards
Men Should Avoid ‘Rhino’ Sexual Enhancement Products, FDA Says
Reports include chest pain, severe headaches, prolonged erections after taking Rhino products.
Next post in Men's Health Update
